Clara Fonteneau

ORCID: 0000-0003-2808-3867
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Functional Brain Connectivity Studies
  • Mental Health Research Topics
  • Advanced Neuroimaging Techniques and Applications
  • Transcranial Magnetic Stimulation Studies
  • Neural and Behavioral Psychology Studies
  • Neural dynamics and brain function
  • Schizophrenia research and treatment
  • Treatment of Major Depression
  • Spatial Neglect and Hemispheric Dysfunction
  • Advanced MRI Techniques and Applications
  • Visual perception and processing mechanisms
  • Neuroscience and Music Perception
  • Tryptophan and brain disorders
  • Neurotransmitter Receptor Influence on Behavior
  • Obsessive-Compulsive Spectrum Disorders
  • Health Systems, Economic Evaluations, Quality of Life
  • Health, Environment, Cognitive Aging
  • Receptor Mechanisms and Signaling
  • EEG and Brain-Computer Interfaces
  • Bipolar Disorder and Treatment
  • Pharmaceutical studies and practices
  • Migraine and Headache Studies
  • Creativity in Education and Neuroscience
  • Medical Imaging Techniques and Applications
  • Cognitive Science and Mapping

Centre Hospitalier Le Vinatier
2016-2025

Inserm
2014-2025

Centre National de la Recherche Scientifique
2014-2025

Université Claude Bernard Lyon 1
2014-2025

Centre de Recherche en Neurosciences de Lyon
2014-2025

Yale University
2020-2024

Connecticut Mental Health Center
2024

A single transcranial direct current stimulation (tDCS) session applied over the dorsolateral prefrontal cortex (DLFPC) can be associated with procognitive effects. Furthermore, repeated DLPFC tDCS sessions are under investigation as a new therapeutic tool for range of neuropsychiatric conditions. possible mechanism explaining such beneficial effects is modulation meso-cortico-limbic dopamine transmission. We explored spatial and temporal neurobiological bifrontal on subcortical transmission...

10.1093/cercor/bhy093 article EN cc-by-nc Cerebral Cortex 2018-04-09
Cassandra Wannan Barnaby Nelson Jean Addington Kelly Allott Alan Anticevic and 95 more Celso Arango Justin T. Baker Carrie E. Bearden Tashrif Billah Sylvain Bouix Matthew R. Broome Kate Buccilli Kristin S. Cadenhead Monica E. Calkins Tyrone D. Cannon Guillermo Cecci Eric Chen Kang Ik K. Cho Jimmy Choi Scott Clark Michael Coleman Philippe Conus Cheryl M. Corcoran Barbara A. Cornblatt Covadonga M. Díaz‐Caneja Dominic Dwyer Bjørn H. Ebdrup Lauren M. Ellman Paolo Fusar‐Poli Liliana Galindo Pablo A. Gaspar Carla Gerber Louise Birkedal Glenthøj Robert J. Glynn Michael P. Harms Leslie E. Horton René S. Kahn Joseph Kambeitz Lana Kambeitz‐Ilankovic John M. Kane Tina Kapur Matcheri S. Keshavan Sung‐Wan Kim Nikolaos Koutsouleris Marek Kubicki Jun Soo Kwon Kerstin Langbein Kathryn E. Lewandowski Gregory A. Light Daniel Mamah Patricia Marcy Daniel H. Mathalon Patrick D. McGorry Vijay A. Mittal Merete Nordentoft Ángela Núñez Ofer Pasternak Godfrey D. Pearlson Jesús Pérez Diana O. Perkins Albert R. Powers David R. Roalf Fred W. Sabb Jason Schiffman Jai Shah Stefan Smesny Jessica Spark William S. Stone Gregory P. Strauss Zailyn Tamayo John Torous Rachel Upthegrove Márk Vangel Swapna Verma Jijun Wang Inge Winter-van Rossum Daniel H. Wolf Phillip Wolff Stephen J. Wood Alison R. Yung Carla Agurto Mario Álvarez‐Jiménez G. Paul Amminger Marco Armando Ameneh Asgari-Targhi John D. Cahill Ricardo E. Carrión Eduardo Castro Suheyla Cetin‐Karayumak M. Mallar Chakravarty Youngsun Cho David Cotter Simon D’Alfonso Michaela Ennis Shreyas Fadnavis Clara Fonteneau Caroline X. Gao Tina Gupta Raquel E. Gur Ruben C. Gur

Abstract This article describes the rationale, aims, and methodology of Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ). is largest international collaboration to date that will develop algorithms predict trajectories outcomes individuals at clinical high risk (CHR) for psychosis advance development use novel pharmacological interventions CHR individuals. We present a description participating research networks data processing analysis coordination center, their processes...

10.1093/schbul/sbae011 article EN cc-by Schizophrenia Bulletin 2024-03-07

Introduction Neuroimaging technology has experienced explosive growth and transformed the study of neural mechanisms across health disease. However, given diversity sophisticated tools for handling neuroimaging data, field faces challenges in method integration, particularly multiple modalities species. Specifically, researchers often have to rely on siloed approaches which limit reproducibility, with idiosyncratic data organization limited software interoperability. Methods To address these...

10.3389/fninf.2023.1104508 article EN cc-by Frontiers in Neuroinformatics 2023-04-05

Background: Ketamine has emerged as one of the most promising therapies for treatment-resistant depression. However, inter-individual variability in response to ketamine is still not well understood and it unclear how ketamine’s molecular mechanisms connect its neural behavioral effects. Methods: We conducted a single-blind placebo-controlled study, with participants blinded their treatment condition. 40 healthy received acute (initial bolus 0.23 mg/kg, continuous infusion 0.58 mg/kg/hr)....

10.7554/elife.84173 article EN cc-by eLife 2024-04-17

Auditory verbal hallucinations (AVH) of schizophrenia are associated with a disrupted connectivity between frontal and temporoparietal language areas. We hypothesized that this dysconnectivity is underpinned by white matter abnormalities in the left arcuate fasciculus, main fiber bundle connecting speech production perception therefore investigated relationship AVH severity integrity fasciculus measured diffusion tensor imaging (DTI) tractography patients schizophrenia. Thirty-eight...

10.1016/j.nicl.2016.04.013 article EN cc-by-nc-nd NeuroImage Clinical 2016-02-01

Difficulties in advancing effective patient-specific therapies for psychiatric disorders highlight a need to develop stable neurobiologically grounded mapping between neural and symptom variation. This gap is particularly acute psychosis-spectrum (PSD). Here, sample of 436 PSD patients spanning several diagnoses, we derived replicated dimensionality-reduced space across hallmark psychopathology symptoms cognitive deficits. In turn, these axes mapped onto distinct, reproducible brain maps....

10.7554/elife.66968 article EN cc-by eLife 2021-07-20

Abstract Decades of research have highlighted the importance optimal stimulation cortical dopaminergic receptors, particularly D1R receptor (D1R), for prefrontal-mediated cognition. This mechanism is relevant to cognitive deficits in schizophrenia, given abnormalities dopamine (DA) neurotransmission and expression D1R. Despite critical need D1R-based therapeutics, many factors complicated their development prevented this important therapeutic target from being adequately interrogated....

10.1093/schbul/sbab095 article EN Schizophrenia Bulletin 2021-07-20

Each cortical area has a distinct pattern of anatomical connections within the thalamus, central subcortical structure composed functionally and structurally nuclei. Previous studies have suggested that certain areas may more extensive target multiple thalamic nuclei, which potentially allows them to modulate distributed information flow. However, there is lack quantitative investigations into connectivity patterns thalamus. Consequently, it remains unknown if exhibit systematic differences...

10.7554/elife.95018 preprint EN 2024-02-29

Deficits in working memory (WM) are a hallmark of neuropsychiatric disorders such as schizophrenia, yet their neurobiological basis remains poorly understood. Glutamate N-methyl-D-aspartate receptors (NMDARs) critical for spatial WM (sWM), with NMDAR antagonist ketamine known to attenuate task-evoked activation and reduce sWM accuracy. Cortical microcircuit models hypothesize that antagonism impairs by broadening neural tuning, but this mechanism has not been directly tested humans. Using...

10.1101/2025.02.10.637233 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2025-02-12

Despite decades of research, cognitive impairment remains a critical untreated symptom for many patients with schizophrenia. One way to accelerate the development pro-cognitive therapies schizophrenia is evaluate compounds using biomarker approaches tailored relevant neural mechanisms. While D1/D5 receptor (D1R/D5R) agonism has been extensively studied in neuroscience, its therapeutic potential untapped. The Translational Neuroscience & Computational Evaluation D1R Partial Agonist...

10.1101/2025.04.18.25326082 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2025-04-20

Abstract Auditory verbal hallucinations (AVH) in patients with schizophrenia are linked to abnormalities within a large cerebral network including frontal and temporal regions. Whilst of speech production perception regions have been extensively studied, alterations the dorsolateral prefrontal cortex (DLPFC), region critically involved pathophysiology schizophrenia, rarely studied relation AVH. Using 1.5 T proton magnetic resonance spectroscopy, this study examined relationship between right...

10.1038/s41598-018-22597-y article EN cc-by Scientific Reports 2018-03-01

Neural activity and behavior vary within an individual (states) between individuals (traits). However, the mapping of state-trait neural variation to is not well understood. To address this gap, we quantify moment-to-moment changes in brain-wide co-activation patterns derived from resting-state functional magnetic resonance imaging. In healthy young adults, identify reproducible spatio-temporal features at single subject level. We demonstrate that a joint analysis variations feature...

10.1101/2023.09.18.557763 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2023-09-19

Neuroimaging technology has experienced explosive growth and transformed the study of neural mechanisms across health disease. However, given diversity sophisticated tools for handling neuroimaging data, field faces challenges in method integration (1–3), particularly multiple modalities species. Specifically, researchers often have to rely on siloed approaches which limit reproducibility, with idiosyncratic data organization limited software interoperability. To address these challenges, we...

10.1101/2022.06.03.494750 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2022-06-05

This paper proposes an innovative method, named b-ntPET, for solving a competition model in PET. The is built upon the state-of-the-art method called lp-ntPET. It consists identifying parameters of PET kinetic relative to reference region that rule steady state exchanges, together with identification four additional defining displacement curve caused by endogenous neurotransmitter discharge, or competing injected drug targeting same receptors as tracer. resolution process lp-ntPET however...

10.3389/fphys.2020.00498 article EN cc-by Frontiers in Physiology 2020-05-19

Each cortical area has a distinct pattern of anatomical connections within the thalamus, central subcortical structure composed functionally and structurally nuclei. Previous studies have suggested that certain areas may more extensive target multiple thalamic nuclei, which potentially allows them to modulate distributed information flow. However, there is lack quantitative investigations into connectivity patterns thalamus. Consequently, it remains unknown if exhibit systematic differences...

10.7554/elife.95018.1 preprint EN 2024-02-29

Neural activity and behavior vary within an individual (states) between individuals (traits). However, the mapping of state-trait neural variation to is not well understood. To address this gap, we quantify moment-to-moment changes in brain-wide co-activation patterns derived from resting-state functional magnetic resonance imaging. In healthy young adults, identify reproducible spatiotemporal features at single-subject level. We demonstrate that a joint analysis variations feature reduction...

10.1371/journal.pbio.3002808 article EN cc-by PLoS Biology 2024-09-24
Coming Soon ...